Description
PRODUCT OVERVIEW
A Modified Peptide Investigated in GHRH Signaling
CJC-1295 with DAC is designed to interact with the growth hormone-releasing hormone receptor. The DAC modification distinguishes it from versions marketed without DAC and is associated with prolonged circulation.
Scientific research has examined its effects on growth hormone secretion and related signaling. These findings do not establish clinical benefits or confirm the safety, efficacy, or quality of the specific material offered by THRYVE.
PRODUCT SPECIFICATIONS
| Specification | Details |
| Product Name | CJC-1295 With DAC |
| Compound Classification | Synthetic peptide research compound |
| Research Classification | Long-acting GHRH analogue |
| DAC Modification | Drug Affinity Complex modification |
| Available Quantity | 5 mg, as listed. |
| Price | $99.00 |
SCIENTIFIC BACKGROUND
CJC-1295 with DAC has been investigated for its interaction with GHRH receptors and its effects on growth hormone and IGF-1 concentrations. The DAC modification enables albumin binding, which contributes to a longer duration in circulation compared with unmodified GHRH.
However, human safety data remain limited, and the compound is not an FDA-approved medicine. Research findings should not be interpreted as proof of clinical efficacy or suitability for human use.
RESEARCH APPLICATIONS
- Investigation of GHRH receptor signaling.
- Study of growth hormone-related biological pathways.
- Analysis of peptide structure and DAC modification.
- Analytical characterization and evaluation of peptide identity.
- Review of applicable product and lot documentation.
The relevance of these research areas depends on the study design, verified material identity, and appropriate laboratory methods.
QUALITY & LABORATORY DOCUMENTATION
Products are supported by applicable third-party laboratory testing documentation. Independent verification and additional testing may be conducted where appropriate.
Documentation availability and testing scope may vary by supplier and lot. Supplier-provided reports should not be represented as directly verified by THRYVE unless that verification has occurred.
VIEW AVAILABLE DOCUMENTATION
LOT & BATCH REFERENCE
Where lot or batch identifiers and corresponding records are available, researchers should confirm that the documentation applies to the specific material supplied.
STORAGE & HANDLING
Follow applicable supplier documentation for storage conditions and handling requirements. Maintain appropriate laboratory records and handling procedures.
RESEARCH USE STATEMENT
For laboratory and scientific research use only.
This product is not offered for human or veterinary use or consumption. It is not intended for diagnosis, treatment, cure, or prevention of any disease. No dosing or administration guidance is provided.
IMPORTANT NOTICE
Product identity, DAC modification, specifications, and analytical characteristics should be confirmed against applicable supplier documentation. Scientific findings do not establish clinical efficacy, safety, or therapeutic benefit.
Not for human or veterinary use or consumption.

Reviews
There are no reviews yet.